Skip to main content
Journal of General and Family Medicine logoLink to Journal of General and Family Medicine
. 2020 May 16;21(4):159–160. doi: 10.1002/jgf2.322

Pulmonary damage caused by lamotrigine

Yusuke Mon 1,, Chisato Tamaki 1
PMCID: PMC7388667  PMID: 32742910

Abstract

This is the first Japanese case of pulmonary damage caused by lamotrigine.

graphic file with name JGF2-21-159-g003.jpg

Keywords: drug reaction with eosinophilia and systemic symptoms, drug‐induced hypersensitivity syndrome, lamotrigine, pulmonary damage


A 69‐year‐old man was admitted to our hospital due to generalized eruption for a week (Figure 1). He had been treated for poststroke epilepsy by lamotrigine, which had been started and increased according to the protocol for 40 days before the advent of eruption.

Figure 1.

Figure 1

Eruption of lower legs

We stopped lamotrigine and started oral prednisolone 10mg/day. Eruption gradually faded; however, high fever (up to 40°C) appeared, laboratory data showed eosinophilia (1.9 × 109/L, 22.9%) and slight elevations in liver enzymes (AST: 53 U/L, ALT: 31 U/L), and chest CT scan revealed ground glass opacities on both lungs (Figure 2). We started steroid therapy with 1 g of methylprednisolone for 3 days and continued prednisolone for several weeks. The temperature went down, and the ground glass opacities subsided gradually. We did not perform bronchoscopy; therefore, we did not obtain pathological material and bronchoalveolar lavage fluid.

Figure 2.

Figure 2

Ground glass opacities on both lungs

Lamotrigine is one of the drugs which cause skin eruption and drug‐induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) 1 ; however, reports of pulmonary damage are rare. 2 This case satisfied the criteria for DRESS, but not for DiHS. And anti‐HHV‐6 IgG titer (FA) did not significantly change during the interval of two weeks (from 20 to 10). This is the first Japanese case of pulmonary damage caused by lamotrigine.

CONFLICT OF INTERESTS

The authors have stated explicitly that there are no conflicts of interest in connection with this article.

PATIENT CONSENT

Patient consent was obtained before publishing this case report.

ACKNOWLEDGEMENTS

We would like to thank the patient and the family who approved this paper.

Mon Y, Tamaki C. Pulmonary damage caused by lamotrigine. J Gen Fam Med. 2020;21:159–160. 10.1002/jgf2.322

REFERENCES

  • 1. Tetsuo S, Yoshiko M. Drug‐induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68:301–8. [DOI] [PubMed] [Google Scholar]
  • 2. Ghandourah H, Bhandal S, Brundler M, Noseworthy M. Case Report Bronchiolitis obliterans organising pneumonia associated with anticonvulsant hypersensitivity syndrome induced by lamotrigine. BMJ Case Rep. 2016;2016:bcr2014207182. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of General and Family Medicine are provided here courtesy of Wiley

RESOURCES